BR112016028066A2 - composição de vacina; idessuis; ridessuis; anticorpo; composição parenteral; uso de uma proteína idessuis ou ridessuis; e célula hospedeira - Google Patents

composição de vacina; idessuis; ridessuis; anticorpo; composição parenteral; uso de uma proteína idessuis ou ridessuis; e célula hospedeira

Info

Publication number
BR112016028066A2
BR112016028066A2 BR112016028066A BR112016028066A BR112016028066A2 BR 112016028066 A2 BR112016028066 A2 BR 112016028066A2 BR 112016028066 A BR112016028066 A BR 112016028066A BR 112016028066 A BR112016028066 A BR 112016028066A BR 112016028066 A2 BR112016028066 A2 BR 112016028066A2
Authority
BR
Brazil
Prior art keywords
ridessuis
idessuis
composition
antibody
protein
Prior art date
Application number
BR112016028066A
Other languages
English (en)
Inventor
BAUMS Christoph
Seele Jana
Valentin-Weigand Peter
Original Assignee
Idt Biologika Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50846835&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112016028066(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idt Biologika Gmbh filed Critical Idt Biologika Gmbh
Publication of BR112016028066A2 publication Critical patent/BR112016028066A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

é descrita uma composição de vacina compreendendo uma quantidade eficaz de pelo menos um polipeptídeo selecionado a partir do grupo de idessuis, ridessuis, um análogo ou um fragmento destes, ou um polinucleotídeo que codifica os mesmos. essa composição de vacina é utilizada para tratamento profilático, metafilático ou terapêutico de uma infecção por streptococcus suis em suínos ou seres humanos.
BR112016028066A 2014-05-30 2015-05-29 composição de vacina; idessuis; ridessuis; anticorpo; composição parenteral; uso de uma proteína idessuis ou ridessuis; e célula hospedeira BR112016028066A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14170637.4A EP2949340A1 (en) 2014-05-30 2014-05-30 Vaccine composition against Streptococcus suis infection
PCT/EP2015/061961 WO2015181356A1 (en) 2014-05-30 2015-05-29 Vaccine composition against streptococcus suis infection

Publications (1)

Publication Number Publication Date
BR112016028066A2 true BR112016028066A2 (pt) 2017-10-24

Family

ID=50846835

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016028066A BR112016028066A2 (pt) 2014-05-30 2015-05-29 composição de vacina; idessuis; ridessuis; anticorpo; composição parenteral; uso de uma proteína idessuis ou ridessuis; e célula hospedeira

Country Status (20)

Country Link
US (3) US20170209561A1 (pt)
EP (3) EP2949340A1 (pt)
JP (2) JP6670304B2 (pt)
KR (1) KR102480824B1 (pt)
CN (2) CN113769076A (pt)
AU (1) AU2015265884B2 (pt)
BR (1) BR112016028066A2 (pt)
CA (1) CA2947798A1 (pt)
DE (1) DE202015009979U1 (pt)
DK (1) DK3148576T3 (pt)
ES (1) ES2846698T3 (pt)
HU (1) HUE053084T2 (pt)
MX (1) MX2016015821A (pt)
MY (1) MY178365A (pt)
NZ (1) NZ726364A (pt)
PL (1) PL3148576T3 (pt)
PT (1) PT3148576T (pt)
RU (1) RU2735101C2 (pt)
WO (1) WO2015181356A1 (pt)
ZA (1) ZA201607627B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2949340A1 (en) 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
EP3319630A1 (en) * 2015-07-09 2018-05-16 Intervacc AB Vaccine against s.suis infection
WO2018175783A1 (en) * 2017-03-22 2018-09-27 Modernatx, Inc. Rna bacterial vaccines
WO2019025517A1 (en) * 2017-08-03 2019-02-07 Intervet International B.V. VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS AM
EP3675901A1 (en) * 2017-08-31 2020-07-08 Boehringer Ingelheim Animal Health USA Inc. Streptococcus suis vaccines to protect against reproductive, nursery-age, and growing pig diseases and methods of making and use thereof
JP2021506782A (ja) * 2017-12-15 2021-02-22 インターベット インターナショナル ベー． フェー． レンサ球菌感染防御のためのワクチン
CN111447946A (zh) * 2017-12-15 2020-07-24 英特维特国际股份有限公司 用于针对猪链球菌进行保护的疫苗
US20220339276A1 (en) * 2017-12-15 2022-10-27 Intervet Inc. A vaccine for protection against streptococcus suis
EP3549600A1 (en) * 2018-04-03 2019-10-09 Intervet International B.V. A vaccine for protection against streptococcus suis
KR102073086B1 (ko) * 2018-06-04 2020-02-04 (주)인트론바이오테크놀로지 신규한 스트렙토코커스 수이스 박테리오파지 Str-SUP-1 및 이의 스트렙토코커스 수이스 균 증식 억제 용도
CN112638409B (zh) 2018-08-27 2024-05-07 英特维特国际股份有限公司 组合疫苗
JP2022506634A (ja) * 2018-11-08 2022-01-17 インターベット インターナショナル ベー． フェー． 豚レンサ球菌感染防御のためのワクチン
ES2937136T3 (es) 2018-11-23 2023-03-24 Intervet Int Bv Vacuna de antígeno de proteasa IgM para proteger contra Streptococcus suis
KR102524577B1 (ko) * 2019-04-22 2023-04-21 전남대학교산학협력단 플라젤린 융합 단백질 및 이의 용도
WO2021073778A1 (en) 2019-10-14 2021-04-22 Ceva Sante Animale Compositions and methods for vaccinating piglets against streptococcus
JP2023503057A (ja) 2019-11-20 2023-01-26 インターベット インターナショナル ベー． フェー． ヘモフィルス・パラスイスに対する新規ワクチン
US20220387577A1 (en) 2019-11-20 2022-12-08 Intervet Inc. A novel vaccine against heamophilus parasuis
JP2023503058A (ja) 2019-11-20 2023-01-26 インターベット インターナショナル ベー． フェー． ヘモフィルス・パラスイスに対する新規ワクチン
BR112022017316A2 (pt) 2020-03-14 2022-10-11 Intervet Int Bv Vacina para proteção contra streptococcus suis de sorotipo 9, sequência tipo 16
CN112410310A (zh) * 2020-10-28 2021-02-26 天津农学院 一种猪链球菌疫苗重组蛋白gse及其制备方法和应用
CN113444694B (zh) * 2021-06-22 2022-09-30 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种噬菌体sp2019-lx株及其在制备腺疫治疗性药物中的应用
CN113332421B (zh) * 2021-07-02 2022-07-19 江苏省农业科学院 一种猪链球菌病疫苗
EP4380610A1 (en) 2021-08-03 2024-06-12 Intervet International B.V. A vaccine for protection against streptococcus suis of various serotypes
CN117794563A (zh) 2021-08-03 2024-03-29 英特维特国际股份有限公司 用于保护以对抗多种血清型的猪链球菌的疫苗
CN117794565A (zh) 2021-08-03 2024-03-29 英特维特国际股份有限公司 用于保护以对抗多种血清型的猪链球菌的疫苗
WO2023088988A1 (en) 2021-11-18 2023-05-25 Intervet International B.V. A method to produce a vaccine against streptococcus suis and the said vaccine
WO2023203238A1 (en) * 2022-04-22 2023-10-26 Intervacc Ab Streptococcus suis vaccine composition comprising immunogenic fusion polypeptides
WO2024112492A1 (en) * 2022-11-22 2024-05-30 Duke University Compositions comprising antibody cleaving enzymes and method of using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
IL137921A0 (en) * 1998-02-20 2001-10-31 Iaf Biochem Int Group b streptococcus proteins and polypeptides
IL158328A0 (en) * 2001-04-13 2004-05-12 Wyeth Corp Surface proteins of streptococcus pyogenes
DE10239629A1 (de) * 2002-08-23 2004-04-08 Idt Impfstoffwerk Dessau-Tornau Gmbh Nicht-rekombinate Subunit-Vakzine gegen Streptococcus suis-Infektionen des Schweines
PL1943342T3 (pl) * 2005-09-02 2016-12-30 Polipeptydy Streptococcus suis i kodujące je polinukleotydy oraz ich zastosowania w szczepionkach i diagnostyce
EP2227249B1 (en) * 2007-12-13 2018-04-25 Intervacc AB Improved immunizing composition
TW201043242A (en) * 2009-03-26 2010-12-16 Intervet Int Bv Vaccine for protection against Streptococcus suis bacteria of various serotypes
CN103068838B (zh) * 2010-05-26 2016-03-02 英特瓦克公司 基于重组蛋白的抗链球菌感染疫苗
EP2949340A1 (en) 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
CN111447946A (zh) 2017-12-15 2020-07-24 英特维特国际股份有限公司 用于针对猪链球菌进行保护的疫苗

Also Published As

Publication number Publication date
MY178365A (en) 2020-10-09
CA2947798A1 (en) 2015-12-03
MX2016015821A (es) 2017-04-25
CN106561082B (zh) 2021-08-03
EP3148576B8 (en) 2020-12-30
AU2015265884B2 (en) 2021-03-04
PT3148576T (pt) 2021-02-01
EP3148576A1 (en) 2017-04-05
US12036275B2 (en) 2024-07-16
DK3148576T3 (da) 2021-01-18
RU2016146801A3 (pt) 2018-12-10
CN113769076A (zh) 2021-12-10
HUE053084T2 (hu) 2021-06-28
EP3795174A1 (en) 2021-03-24
RU2016146801A (ru) 2018-05-29
AU2015265884A1 (en) 2016-12-08
EP3148576B1 (en) 2020-10-28
JP6670304B2 (ja) 2020-03-18
US20220401543A1 (en) 2022-12-22
PL3148576T3 (pl) 2021-05-04
CN106561082A (zh) 2017-04-12
EP2949340A1 (en) 2015-12-02
KR102480824B1 (ko) 2022-12-22
JP6909268B2 (ja) 2021-07-28
ES2846698T3 (es) 2021-07-28
RU2735101C2 (ru) 2020-10-28
WO2015181356A8 (en) 2016-12-22
ZA201607627B (en) 2020-09-30
JP2017518367A (ja) 2017-07-06
US20170209561A1 (en) 2017-07-27
DE202015009979U1 (de) 2022-05-23
NZ726364A (en) 2023-05-26
WO2015181356A1 (en) 2015-12-03
KR20170005855A (ko) 2017-01-16
US20210015910A1 (en) 2021-01-21
JP2020019816A (ja) 2020-02-06

Similar Documents

Publication Publication Date Title
BR112016028066A2 (pt) composição de vacina; idessuis; ridessuis; anticorpo; composição parenteral; uso de uma proteína idessuis ou ridessuis; e célula hospedeira
CO2017006580A2 (es) Anticuerpos humanos para hemaglutinina de influenza
BR112018074463A2 (pt) anticorpos anti-tim-3 e métodos de uso dos mesmos.
BR112017008165A2 (pt) anticorpos de domínio único direcionados contra antígenos intracelulares
BR112016025009A2 (pt) anticorpos humanos para a síndrome respiratória do oriente médio - proteína de superfície
BR112019001737A2 (pt) expressão de pten-long com vírus oncolíticos
BR112017023646A2 (pt) proteínas agonistas de receptor de cd40 de cadeia simples
BR112018007017A2 (pt) polipeptídeos
BR112018006251A2 (pt) anticorpos antagonistas que se ligam especificamente a cd40 humano e métodos de uso
BR112016028288A2 (pt) ?composto, composição farmacêutica, métodos para tratamento de um indivíduo com uma doença ou condição e para inibir a quinase, e, uso de um composto?
BR112015031475A2 (pt) composto, composição farmacêutica, método para tratamento de uma doença ou condição, kit, e, uso de composto.
BR112016022814A8 (pt) composição farmacêutica e seu método de preparação, ácido nucleico, e dispositivo médico ou kit médico
BR112016023979A2 (pt) métodos de melhora ou aceleração da recuperação física após cirurgia para fratura óssea
BR112015029788A2 (pt) hetero-multímero, construto de anticorpo isolado, ácido nucleico, célula hospedeira, método para preparar o hetero-multímero, composição farmacêutica, método para tratar uma doença, uso do hetero-multímero, uso de uma quantia terapêutica do hetero-multímero e método para reduzir a função efetora de um construto de anticorpo
BR112018072723A2 (pt) composição, e, métodos para tratar uma doença em um sujeito e para aumentar uma resposta imunológica em um sujeito
BR112015030356A2 (pt) métodos de tratamento de uma taupatia
BR112016024515A2 (pt) proteínas do agonista do receptor trail de cadeia única
CL2016002794A1 (es) Vacuna de péptido que comprende un péptido ras mutante y un agente quimioterapéutico
BR112017011556A2 (pt) métodos para gerar um anticorpo sintético, prevenir ou tratar uma doença, tratar um sujeito de infecção por um patógeno e um sujeito com câncer, produto, molécula de ácido nucleico, e, composição.
BR112018006006A2 (pt) receptores de antígeno, cadeias peptídicas, células recombinantes, métodos para produzir uma célula que expressa um receptor de antígeno e para o tratamento de uma doença, ácidos nucleicos e composição farmacêutica
BR112017023131A2 (pt) anticorpos anti- fcrn
BR112018002319A2 (pt) anticorpos anti-cd154 e métodos de uso dos mesmos
AR100944A1 (es) ANTICUERPOS ANTAGONISTAS DE INTERFERÓN a Y w
DK3146042T3 (da) Rekombinant klassisk svinepestvirus (CSFV) med substitution i E2-proteinets TAV-epitop
BR112017001782A2 (pt) fragmentos de anticorpo radiomarcados para uso na prevenção e/ou tratamento de câncer

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25A Requested transfer of rights approved

Owner name: CEVA SANTE ANIMALE S.A. (FR)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]